LONDON, March 16 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for two years over what the ...
A U.K. pharma trade group suspended Novo Nordisk’s membership for two years after marketing efforts for its obesity drug were deemed a breach of the group’s standards. ABPI said it took the action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results